DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reclast (Zoledronic Acid) - Femur Fracture - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Femur Fracture (154)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reclast (Zoledronic Acid) where reactions include femur fracture. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 154   Next >>

Possible Reclast side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-24

Patient:

Reactions: Seasonal Allergy, Spinal Compression Fracture, Femur Fracture, Fracture, Bone Disorder, Fall, Open Reduction of Fracture, RIB Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Dosage: 35 mg, unk
    Indication: Osteoporosis
    Start date: 2007-12-31
    End date: 2009-01-01

Fosamax
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2000-01-01
    End date: 2007-06-01

Reclast
    Dosage: unk
    Indication: Osteoporosis
    Start date: 2009-01-01
    End date: 2011-01-01

Other drugs received by patient: Vitamins (Unspecified); Vitamin D; Calcium (Unspecified)



Possible Reclast side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: female

Reactions: HIP Fracture, Pelvic Fracture, Emotional Distress, Femur Fracture, Pain, Injury

Drug(s) suspected as cause:
Boniva

Fosamax

Reclast



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-23

Patient:

Reactions: Foot Deformity, Pruritus, Tinnitus, Contusion, Femur Fracture, Hyperkeratosis, Tachycardia, Headache, Herpes Zoster, Cardiac Disorder, Arthropathy, Palpitations, Postmenopausal Haemorrhage, Joint Effusion, Tympanic Membrane Perforation, LOW Turnover Osteopathy, Back Pain, Cellulitis, Cerumen Impaction, Anaemia, Ear Disorder, Haemorrhagic Anaemia, Bursitis, Gastric Disorder, Flushing, Osteonecrosis, Dysphonia, Benign Neoplasm of Skin, Systemic Lupus Erythematosus, Essential Hypertension, Adverse Drug Reaction, Nail Infection, Fall, Liver Function Test Abnormal, Dermatomyositis, Gastrooesophageal Reflux Disease, Exostosis, Soft Tissue Injury, Urinary Tract Infection, Deafness Neurosensory, Arrhythmia, Carotid Artery Stenosis, Osteoarthritis, Arthralgia, Vertigo, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Indication: Osteoporosis Prophylaxis

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-05-08
    End date: 2008-07-01

Fosamax
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Indication: Osteoporosis Prophylaxis

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-01-01
    End date: 2001-04-01

Prednisone TAB
    Dosage: unk
    Indication: Dermatomyositis
    Start date: 2002-12-01
    End date: 2008-02-01

Reclast
    Dosage: 5/100 ml
    Indication: Osteoporosis

Other drugs received by patient: Esomeprazole Sodium



Possible Reclast side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Femur Fracture, Oropharyngeal Pain, Sinus Congestion, Radiculopathy, Anaemia Postoperative, Muscle Spasms, Back Pain, Fracture Delayed Union, Pain in Extremity, Gingival Disorder, Helicobacter Infection, Breast Calcifications, Stress Fracture, Haemorrhagic Diathesis, Gastric Polyps, Polyarthritis, Sleep Apnoea Syndrome, Osteoporosis, Upper-Airway Cough Syndrome, Mouth Ulceration, Fracture Nonunion, Hypokalaemia, Dyspnoea Exertional, Nerve Root Lesion, Intervertebral Disc Degeneration, RIB Fracture, Dyspnoea, Urinary Tract Infection, Hyponatraemia, Musculoskeletal Chest Pain, Anxiety, Osteoarthritis, Arthralgia, Impaired Healing, Dysuria, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Dosage: 70 mg, unk

Fosamax
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2009-02-09
    End date: 2010-08-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Start date: 2002-03-20

Fosamax
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2002-04-01
    End date: 2007-12-01

Fosamax Plus D
    Dosage: unk mg, unk
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2008-01-29
    End date: 2008-11-10

Reclast
    Indication: Osteopenia
    Start date: 2010-09-01
    End date: 2011-02-01

Other drugs received by patient: Calcium (Unspecified) (+) Vitamin D (Unspecified); Vitamin E; Esomeprazole Sodium; Calcium (Unspecified) (+) Vitamin D (Unspecified)



Possible Reclast side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 59.0 kg (129.8 pounds)

Reactions: Femur Fracture, Pain in Extremity, Bone Pain, Stress Fracture, Fall, Pathological Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reclast

Other drugs received by patient: Celebrex; Fosamax; Fosamax; Estrogen NOS



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-10

Patient:

Reactions: Femur Fracture, Femoral Nerve Injury, Device Malfunction, Wound Infection Staphylococcal, Fracture Nonunion

Drug(s) suspected as cause:
Forteo
    Dosage: unk
    Start date: 2010-12-01

Fosamax
    Dosage: 70 mg, unk
    Start date: 2002-10-14
    End date: 2008-08-01

Reclast
    Dosage: unk
    Start date: 2008-09-01



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-10

Patient:

Reactions: Femur Fracture

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Fosamax
    Dosage: unk
    Administration route: Oral
    Start date: 1999-01-01
    End date: 2011-06-01

Reclast
    Dosage: unk
    Start date: 1999-01-01
    End date: 2011-06-01



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-10

Patient:

Reactions: Femur Fracture

Drug(s) suspected as cause:
Alendronate Sodium
    Indication: Osteopenia

Fosamax
    Dosage: unk
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2003-01-01

Reclast
    Dosage: unk
    Indication: Osteopenia
    Start date: 2009-01-01



Possible Reclast side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: 58 year old female

Reactions: Osteoporotic Fracture, Femur Fracture, Pain, Fracture Nonunion, Groin Pain, Muscle Injury, Fracture Displacement, Bone Disorder, Pathological Fracture, Haematoma, LOW Turnover Osteopathy, Fracture Delayed Union, Mass, Dysstasia, Monoparesis, Arthralgia, Stress Fracture, Mobility Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Dosage: 35 mg once weekly, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2004-12-06
    End date: 2009-03-13

Boniva
    Dosage: 150 mg once monthly, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2006-03-06
    End date: 2009-11-30

Fosamax
    Dosage: 70 mg single dose, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-09-29
    End date: 2005-09-29

Reclast
    Indication: Osteoporosis
    Start date: 2010-11-01
    End date: 2011-11-29

Other drugs received by patient: Synthroid; Butalbital / Apap (Butalbital, Paracetamol); Lunesta; Axert; Aciphex; Paroxetine Hydrochloride; Mirtazapine; Cymbalta; Doxepin HCL; Fexofenadine; Hydroxyzine Pamoate; Vagifem; Benztropine Mesylate; Haloperidol Lactate; Seroquel; Prevalite; Gabitril; Meclizine / 00072801 / (Meclozine); Quinine Sulfate; Nitrofurantoin; Tramadol / Apap (Paracetamol, Tramadol Hydrochloride); Mupirocin; Excedrin Migraine (Acetylsalicylic Acid, Caffeine, Paracetamol); Prevident (Sodium Fluoride); Micardis; Zomig; Amoxicillin; Topamax; Doxazosin Mesylate; Carisoprodol; Nystatin W / Triamcinolone / 00945901 / (Nystatin, Triamcinolone Acetonide; Chloral Hydrate (Chloral Hydrate); Apap W / Codeine (Codeine, Paracetamol); Antipyrine W / Benzocaine (Benzocaine, Phenazone); Enablex / 01760401 / (Darifenacin); Triamcinolone; Zofran / 00955301 / (Ondansetron); Norvasc; Zyrtec; Terazosin HCL; Naltrexone Hydrochloride; Allegra-D 12 Hour; Orphenadrine Citrate; Sonata / 01454001 / (Zaleplon); Ciprofloxacin; Clonazepam; Pyridium (Phenazopyridine Hydrochloride); Cyclobenzaprine; Clarinex / 01398501 / (Deslortadine); Cimetidine; Vitamin C / 00008001 / (Ascorbic Acid); Vitamin B12; Precose; Folplex (Cyanocobalamin, Folic Acid, Pyridoxine Hydrochloride); Carafate; Chlorpromazine; Premarin; Fergon; Centrum Silver / 01292501 / (Ascorbic Acid, Calcium, Minerals Nos, Retin



Possible Reclast side effects in 94 year old female

Reported by a pharmacist from United States on 2012-08-09

Patient: 94 year old female, weighing 76.2 kg (167.6 pounds)

Reactions: Femur Fracture, Stress Fracture, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reclast



Possible Reclast side effects in 69 year old female

Reported by a physician from United States on 2012-08-09

Patient: 69 year old female

Reactions: Femur Fracture, Stress Fracture

Drug(s) suspected as cause:
Boniva
    Indication: Osteoporosis
    Start date: 2007-01-01
    End date: 2008-01-01

Reclast
    Indication: Osteoporosis
    Start date: 2010-09-01
    End date: 2011-11-01



Possible Reclast side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: Foot Deformity, Femur Fracture, Pruritus, Hyperkeratosis, Tinnitus, Contusion, Tachycardia, Headache, Cardiac Disorder, Herpes Zoster, Arthropathy, Palpitations, Postmenopausal Haemorrhage, Tympanic Membrane Perforation, Joint Effusion, LOW Turnover Osteopathy, Back Pain, Cellulitis, Cerumen Impaction, Anaemia, Ear Disorder, Bursitis, Haemorrhagic Anaemia, Gastric Disorder, Flushing, Osteonecrosis, Benign Neoplasm of Skin, Dysphonia, Systemic Lupus Erythematosus, Essential Hypertension, Adverse Drug Reaction, Fall, Nail Infection, Liver Function Test Abnormal, Dermatomyositis, Gastrooesophageal Reflux Disease, Exostosis, Soft Tissue Injury, Urinary Tract Infection, Deafness Neurosensory, Arrhythmia, Carotid Artery Stenosis, Osteoarthritis, Arthralgia, Vertigo, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-02-01
    End date: 2008-01-01

Alendronate Sodium
    Indication: Osteoporosis Prophylaxis

Fosamax
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Indication: Osteoporosis Prophylaxis

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-05-08
    End date: 2008-07-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-01-01
    End date: 2001-04-01

Prednisone
    Dosage: unk
    Indication: Dermatomyositis
    Start date: 2002-12-01
    End date: 2008-02-01

Reclast
    Dosage: 5/100 ml
    Indication: Osteoporosis

Other drugs received by patient: Esomeprazole



Possible Reclast side effects in 73 year old female

Reported by a physician from United States on 2012-08-05

Patient: 73 year old female

Reactions: Femur Fracture, Bone Pain, Fall, Fracture Nonunion, Groin Pain, Joint Range of Motion Decreased, Fracture Displacement, Carpal Tunnel Syndrome, Pathological Fracture, Anaemia Postoperative, Pain in Extremity, Muscular Weakness, Osteopenia, Hypoaesthesia, Paraesthesia, Radiculitis Lumbosacral, Osteoarthritis, Activities of Daily Living Impaired, Impaired Healing, Arthralgia, Procedural Hypotension, Limb Asymmetry, Procedural Dizziness, Gait Disturbance, Traumatic Haematoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Dosage: 35 mg weekly, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2003-01-01

Boniva
    Dosage: 150 mg once monthly, oral
    Administration route: Oral
    Start date: 2008-01-10
    End date: 2008-03-14

Fosamax
    Dosage: 10 mg daily, oral ; 10 mg, daily, oral
    Administration route: Oral
    Start date: 1999-03-10
    End date: 2000-12-15

Fosamax
    Dosage: 70 mg once weekly, oral
    Administration route: Oral
    Start date: 2001-01-15
    End date: 2002-12-20

Reclast
    Dosage: 5 mg/100 ml 5 mg

Other drugs received by patient: Neurontin; Celebrex; Azulfidine; Xalatan / 01297301 / (Latanoprost); Simcor / 03020801 / (Nicotinic Acid, Simvastatin); Methocarbamol; Darvocet / 00758701 / (Dextropropoxyphene Napsilate, Paracetamol); Calcium Carbonate; Magnesium (Magnesium); Forteo; Chromium Picolinate (Chromium Picolinate); Baclofen; Nexium; Synthroid; Allegra / 01314202 / (Fexofenadine Hydrochloride); Oxycodone W / Paracetamol (Oxycodone, Paracetamol); Colchicine; Zinc (Zinc); Fish OIL (Fish Oil); Corticosteroids; Lovaza; Aspirin; B Complex / 00322001 / (Calcium Pantothenate, Cyanocobalamin, Nicotinami



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-03

Patient:

Reactions: Bunion, Femur Fracture, Sciatica, Headache, Fall, Colonic Polyp, Blood Pressure Inadequately Controlled, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Depression, Pathological Fracture, RIB Fracture, Breast Cancer, Back Pain, Migraine, Excoriation, Urinary Tract Infection, Anaemia, Cholecystitis Chronic, Alcohol Poisoning, Anxiety, Hyperlipidaemia, Panic Attack, Diverticulum, Osteotomy, Compression Fracture, Stress Fracture, Otitis Media, Incision Site Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2002-01-30
    End date: 2008-08-01

Fosamax
    Indication: Osteopenia

Reclast
    Dosage: iv given yearly
    Indication: Osteopenia
    Start date: 2008-01-01

Other drugs received by patient: Prilosec; Nasonex; Calcium (Unspecified); Singulair; Prevacid



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-08-03

Patient:

Reactions: Femur Fracture, JAW Disorder, Tooth Disorder

Drug(s) suspected as cause:
Forteo
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    Indication: Osteoporosis

Reclast
    Indication: Osteoporosis



Possible Reclast side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female

Reactions: Nerve Injury, Anxiety, Emotional Distress, Femur Fracture, Staphylococcal Infection, Post Procedural Complication, Fracture Nonunion, Post Procedural Infection

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Fosamax
    Dosage: 70 mg
    Indication: Osteoporosis
    Start date: 2002-10-14
    End date: 2008-08-01

Reclast
    Indication: Osteoporosis
    Start date: 2008-09-01



Possible Reclast side effects in

Reported by a physician from United States on 2012-08-02

Patient:

Reactions: Weight Decreased, Femur Fracture, Gastrointestinal Haemorrhage, Tinnitus, Cardiac Disorder, Arthropathy, Connective Tissue Disorder, Balance Disorder, Peroneal Nerve Palsy, DRY Mouth, Carpal Tunnel Syndrome, Vertebral Foraminal Stenosis, Temperature Intolerance, Gallbladder Disorder, Thoracic Vertebral Fracture, LOW Turnover Osteopathy, Anaemia Postoperative, Functional Gastrointestinal Disorder, Fracture Delayed Union, Pain in Extremity, Anaemia, Lumbar Radiculopathy, Osteopenia, Epicondylitis, Joint Swelling, Stiff Person Syndrome, Sleep Apnoea Syndrome, Spinal Column Stenosis, Bunion, Glaucoma, Necrosis, Parathyroid Disorder, Fall, Fracture Nonunion, Abdominal Pain Upper, Groin Pain, Neuropathy Peripheral, Chondrocalcinosis Pyrophosphate, Hyperparathyroidism, Chest Pain, Intervertebral Disc Degeneration, Gastrooesophageal Reflux Disease, Migraine, Benign Bone Neoplasm, Dyspnoea, Cataract, Neurogenic Bladder, Urinary Tract Infection, Cervicobrachial Syndrome, Device Failure, Osteoarthritis, Blood Potassium Decreased, Arthralgia, Diarrhoea, Alopecia, Procedural Hypotension, Limb Asymmetry, Vertigo, Spinal Osteoarthritis, Bladder Disorder, Gait Disturbance, DRY Eye

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Actonel
    Indication: Osteopenia

Actonel
    Indication: Osteoporosis

Boniva
    Indication: Osteopenia

Boniva
    Indication: Osteoporosis

Fosamax
    Dosage: 70 mg, unk
    Administration route: Oral
    Start date: 2001-01-15

Fosamax
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1996-01-01
    End date: 2000-12-15

Reclast
    Indication: Osteopenia

Reclast
    Indication: Osteoporosis



Possible Reclast side effects in

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient:

Reactions: Vitamin D Deficiency, Femur Fracture, Cyst, Loss of Consciousness, Abdominal Discomfort, Oedema Peripheral, Raynaud's Phenomenon, Patella Fracture, LOW Turnover Osteopathy, Oral Infection, Gingival Disorder, Joint Swelling, Vision Blurred, Stress Fracture, Abscess, Pneumonia Primary Atypical, Drug Ineffective, Osteoporosis, Pain, Adverse Drug Reaction, Tonic Clonic Movements, Fall, Bone Loss, Neuropathy Peripheral, Road Traffic Accident, Depression, Gastrooesophageal Reflux Disease, Calcium Deficiency, Dental Caries, Synovitis, Anxiety, Osteoarthritis, Osteonecrosis of JAW, Spinal Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Boniva
    Dosage: unk
    Indication: Osteoporosis
    Start date: 2008-08-01

Fosamax
    Dosage: unk
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2003-01-01

Reclast
    Dosage: unk
    Indication: Osteoporosis



Possible Reclast side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-31

Patient: female, weighing 153.0 kg (336.6 pounds)

Reactions: Femur Fracture, Fall

Drug(s) suspected as cause:
Reclast



Possible Reclast side effects in

Reported by a consumer/non-health professional from United States on 2012-07-26

Patient:

Reactions: Foot Deformity, Tinnitus, Femur Fracture, Pruritus, Contusion, Hyperkeratosis, Tachycardia, Headache, Herpes Zoster, Cardiac Disorder, Arthropathy, Palpitations, Joint Effusion, Tympanic Membrane Perforation, LOW Turnover Osteopathy, Back Pain, Cellulitis, Cerumen Impaction, Anaemia, Ear Disorder, Haemorrhagic Anaemia, Bursitis, Gastric Disorder, Flushing, Osteonecrosis, Dysphonia, Benign Neoplasm of Skin, Systemic Lupus Erythematosus, Essential Hypertension, Adverse Drug Reaction, Nail Infection, Fall, Liver Function Test Abnormal, Dermatomyositis, Gastrooesophageal Reflux Disease, Exostosis, Soft Tissue Injury, Deafness Neurosensory, Arrhythmia, Carotid Artery Stenosis, Osteoarthritis, Arthralgia, Vertigo, Arthritis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Alendronate Sodium
    Indication: Osteoporosis Prophylaxis

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1998-01-01
    End date: 2001-04-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2001-05-08
    End date: 2008-07-01

Fosamax
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2008-01-01

Fosamax
    Indication: Osteoporosis Prophylaxis

Prednisone
    Dosage: unk
    Indication: Dermatomyositis
    Start date: 2002-12-01
    End date: 2008-02-01

Reclast
    Dosage: 5/100 ml
    Indication: Osteoporosis

Other drugs received by patient: Esomeprazole



Possible Reclast side effects in

Reported by a lawyer from United States on 2012-07-24

Patient:

Reactions: Femur Fracture

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Fosamax
    Dosage: unk
    Administration route: Oral
    Start date: 1998-07-01
    End date: 2010-01-01

Fosamax
    Dosage: unk
    Start date: 1998-07-01
    End date: 2010-01-01

Fosamax Plus D
    Dosage: unk
    Administration route: Oral
    Start date: 1998-07-01
    End date: 2010-01-01

Reclast
    Dosage: unk
    Start date: 1998-07-01
    End date: 2010-01-01



Possible Reclast side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 49.4 kg (108.8 pounds)

Reactions: Femur Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Reclast

Other drugs received by patient: Protonix; Sertraline Hydrochloride; Petrol LA; Claritin; Metoprolol Succinate; Synthroid



Possible Reclast side effects in

Reported by a physician from United States on 2012-07-20

Patient:

Reactions: Femur Fracture, Myofascial Pain Syndrome, Hand Fracture, Lumbar Spinal Stenosis, Balance Disorder, Benign Breast Neoplasm, Vertebral Foraminal Stenosis, Tendonitis, LOW Turnover Osteopathy, Claustrophobia, Cellulitis, Laceration, Coronary Artery Disease, Bursitis, Haemorrhagic Anaemia, Medical Device Pain, Compression Fracture, Treatment Failure, Hypertrophy, Wrist Fracture, Fall, Hypercholesterolaemia, Road Traffic Accident, Intervertebral Disc Degeneration, Lymphoedema, RIB Fracture, Spinal Cord Compression, Scoliosis, Cataract, Radiculitis Lumbosacral, Osteoarthritis, Hyperlipidaemia, Device Failure, Procedural Hypertension, Meralgia Paraesthetica, Sensory Disturbance, Spinal Osteoarthritis, Tooth Disorder, Hypertension, Deep Vein Thrombosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Start date: 2008-02-01
    End date: 2009-01-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Start date: 2008-09-01
    End date: 2009-10-01

Fosamax
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1995-01-01
    End date: 2008-01-01

Reclast
    Indication: Osteoporosis
    Start date: 2009-11-01

Other drugs received by patient: Omega-3 Marine Triglycerides; Calcium (Unspecified); Cholecalciferol; Multi-Vitamins



Possible Reclast side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: female

Reactions: Emotional Distress, Anxiety, Femur Fracture, Injury, Skeletal Injury, LOW Turnover Osteopathy

Drug(s) suspected as cause:
Alendronate Sodium
    Indication: Osteoporosis

Fosamax
    Indication: Osteoporosis

Reclast
    Indication: Osteoporosis

Zoledronic Acid
    Indication: Osteoporosis



Possible Reclast side effects in female

Reported by a physician from United States on 2012-07-11

Patient: female

Reactions: Femur Fracture, Fall

Drug(s) suspected as cause:
Reclast



Possible Reclast side effects in

Reported by a physician from United States on 2012-07-09

Patient:

Reactions: Femur Fracture, Nasopharyngitis, Uterine Polyp, Sciatica, Headache, Spinal Compression Fracture, Monoclonal Gammopathy, Oedema Peripheral, Postmenopausal Haemorrhage, Unevaluable Event, Temperature Intolerance, Tendonitis, LOW Turnover Osteopathy, Intervertebral Disc Protrusion, Pneumonia, Pain in Extremity, Faecal Incontinence, Bursitis, Ankle Fracture, Insomnia, Type V Hyperlipidaemia, Colitis, Uterine Haemorrhage, Calculus Ureteric, Bunion, Tenosynovitis Stenosans, Pain, Multiple Myeloma, Fracture Nonunion, Fall, Nephrolithiasis, Hypercholesterolaemia, Fatigue, Neck Pain, Intervertebral Disc Degeneration, Depression, Contraindication To Medical Treatment, Migraine, Scoliosis, Cataract, Mass, Nausea, Urinary Tract Infection, Endometrial Cancer Stage I, Muscular Weakness, Multiple Fractures, Hypercalcaemia, Osteoarthritis, Device Failure, Anal Sphincter Atony, Multiple Allergies, Spinal Osteoarthritis, Gait Disturbance, Bronchitis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral

Fosamax
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1996-09-01
    End date: 2001-08-30

Fosamax
    Dosage: 70 mg, unk
    Administration route: Oral
    Start date: 2001-07-01
    End date: 2008-12-01

Reclast
    Dosage: 35 ml, unk
    Indication: Osteopenia
    Start date: 2009-06-10
    End date: 2010-06-10

Other drugs received by patient: Calcium (Unspecified); Botox; Lorazepam; Lioram; Darvon; Ibuprofen; Hormones (Unspecified); Naproxen; Fentanyl; Lidoderm; MK-0130; Ultram; Oxycodone HCL; Soma; Metaxalone; Methadon HCL TAB; Hydrocodone



Possible Reclast side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: 51 year old female

Reactions: Femur Fracture, Osteoporosis, Hand Fracture, Fracture Nonunion, Fall, Foot Fracture, Rheumatoid Arthritis, Arthropathy, Irritable Bowel Syndrome, Fibula Fracture, Pain in Extremity, Condition Aggravated, Bursitis, Ankle Fracture, Osteonecrosis, Arthralgia, Impaired Healing, Tibia Fracture, Stress Fracture

Drug(s) suspected as cause:
Actonel
    Dosage: 105 mg, 1/mouth, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-12-29
    End date: 2010-07-02

Fosamax
    Dosage: qd, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1999-01-09

Fosamax
    Dosage: 70 mg, 1/week, oral
    Administration route: Oral
    Indication: Osteoporosis
    End date: 2006-12-06

Reclast
    Dosage: intravenous infusion once a year, intravenous
    Indication: Osteoporosis
    Start date: 2010-02-18
    End date: 2011-03-30

Other drugs received by patient: Fluocinocide (Fluocinonide); Forteo; Cholecalciferol (Colecalciferol)



Possible Reclast side effects in 54 year old female

Reported by a physician from United States on 2012-07-02

Patient: 54 year old female

Reactions: Bunion, Femur Fracture, Sciatica, Headache, Fall, Colonic Polyp, Blood Pressure Inadequately Controlled, Rotator Cuff Syndrome, Intervertebral Disc Degeneration, Depression, Pathological Fracture, RIB Fracture, Migraine, Breast Cancer, Back Pain, Excoriation, Anaemia, Urinary Tract Infection, Cholecystitis Chronic, Alcohol Poisoning, Anxiety, Hyperlipidaemia, Panic Attack, Osteotomy, Diverticulum, Compression Fracture, Otitis Media

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2002-01-30
    End date: 2008-01-30

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2002-01-30
    End date: 2008-01-30

Reclast
    Dosage: iv given yearly
    Indication: Osteopenia
    Start date: 2008-01-01

Other drugs received by patient: Singulair; Nasonex; Prevacid; Omeprazole; Calcium (Unspecified)



Possible Reclast side effects in 53 year old female

Reported by a physician from United States on 2012-06-29

Patient: 53 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Femur Fracture, Nasopharyngitis, Uterine Polyp, Sciatica, Headache, Spinal Compression Fracture, Monoclonal Gammopathy, Oedema Peripheral, Postmenopausal Haemorrhage, Unevaluable Event, Temperature Intolerance, Tendonitis, LOW Turnover Osteopathy, Intervertebral Disc Protrusion, Pneumonia, Pain in Extremity, Faecal Incontinence, Bursitis, Ankle Fracture, Insomnia, Colitis, Type V Hyperlipidaemia, Calculus Ureteric, Uterine Haemorrhage, Bunion, Tenosynovitis Stenosans, Pain, Multiple Myeloma, Fracture Nonunion, Fall, Hypercholesterolaemia, Nephrolithiasis, Fatigue, Neck Pain, Intervertebral Disc Degeneration, Depression, Contraindication To Medical Treatment, Migraine, Scoliosis, Cataract, Nausea, Mass, Urinary Tract Infection, Muscular Weakness, Endometrial Cancer Stage I, Multiple Fractures, Hypercalcaemia, Device Failure, Osteoarthritis, Anal Sphincter Atony, Multiple Allergies, Spinal Osteoarthritis, Bronchitis, Gait Disturbance, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    Start date: 2001-01-01
    End date: 2008-12-01

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1996-01-01
    End date: 2001-08-01

Fosamax
    Administration route: Oral

Reclast
    Indication: Osteopenia
    Start date: 2009-06-10
    End date: 2010-06-10

Other drugs received by patient: Lorazepam; Naproxen; Metaxalone; Hormones (Unspecified); Ultram; Oxycodone; Methadone Hydrochloride; Soma; Lidoderm; Botox; Hydrocodone; Calcium (Unspecified); Darvon; Ibuprofen; Fentanyl; Zolpidem Tartrate; Cyclobenzaprine Hydrochloride



Possible Reclast side effects in 53 year old female

Reported by a physician from United States on 2012-06-26

Patient: 53 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Femur Fracture, Nasopharyngitis, Uterine Polyp, Sciatica, Headache, Spinal Compression Fracture, Monoclonal Gammopathy, Oedema Peripheral, Postmenopausal Haemorrhage, Temperature Intolerance, Unevaluable Event, Tendonitis, LOW Turnover Osteopathy, Intervertebral Disc Protrusion, Pneumonia, Pain in Extremity, Faecal Incontinence, Bursitis, Ankle Fracture, Insomnia, Colitis, Type V Hyperlipidaemia, Uterine Haemorrhage, Calculus Ureteric, Bunion, Pain, Tenosynovitis Stenosans, Fracture Nonunion, Fall, Hypercholesterolaemia, Nephrolithiasis, Fatigue, Neck Pain, Intervertebral Disc Degeneration, Depression, Contraindication To Medical Treatment, Migraine, Scoliosis, Cataract, Nausea, Mass, Urinary Tract Infection, Endometrial Cancer Stage I, Muscular Weakness, Multiple Fractures, Hypercalcaemia, Device Failure, Osteoarthritis, Anal Sphincter Atony, Multiple Allergies, Bronchitis, Spinal Osteoarthritis, Gait Disturbance, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    Start date: 2001-01-01
    End date: 2008-12-01

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1996-01-01
    End date: 2001-08-01

Reclast
    Indication: Osteopenia
    Start date: 2009-06-10
    End date: 2010-06-10

Other drugs received by patient: Hormones (Unspecified); Darvon; Lorazepam; Zolpidem Tartrate; Fentanyl; Botox; Ultram; Naproxen; Hydrocodone; Metaxalone; Cyclobenzaprine Hydrochloride; Lidoderm; Calcium (Unspecified); Methadone Hydrochloride; Oxycodone; Soma; Ibuprofen



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017